The pharmacokinetics of ketorolac after single postoperative intranasal administration in adolescent Patients

Anesthesia and Analgesia

Volumn 114, Issue 6, 2012, Pages 1270-1276

  Drover, David R ^a   Hammer, Gregory B ^a   Anderson, Brian J ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG TOLERABILITY; HUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INTRANASAL; ADOLESCENT; AGE FACTORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY WEIGHT; CHILD; COMPUTER SIMULATION; FEMALE; HUMANS; KETOROLAC TROMETHAMINE; MALE; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; POSTOPERATIVE CARE;

EID: 84861528338     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31824f92c2     Document Type: Article

References (28)

1. Carney DE, Nicolette LA, Ratner MH, Minerd A, Baesl TJ. Ketorolac reduces postoperative narcotic requirements. J Pediatr Surg 2001;36:76-9
2. Vetter TR, Heiner EJ. Intravenous ketorolac as an adjuVant to pediatric patient-controlled analgesia with morphine. J Clin Anesth 1994;6:110-3
3. Chauhan RD, Idom CB, Noe HN. Safety of ketorolac in the pediatric population after ureteroneocystostomy. J Urol 2001;166:1873-5
4. Gupta A, Daggett C, Drant S, Rivero N, Lewis A. Prospective randomized trial of ketorolac after congenital heart surgery. J Cardiothorac Vasc Anesth 2004;18:454-7
5. Lynn AM, Bradford H, Kantor ED, Seng KY, Salinger DH, Chen J, Ellenbogen RG, Vicini P, Anderson GD. Postoperative ketorolac tromethamine use in infants aged 6-18 months: the effect on morphine usage, safety assessment, and stereospecific pharmacokinetics. Anesth Analg 2007;104:1040-51
6. McAleer SD, Majid O, Venables E, Polack T, Sheikh MS. Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers. J Clin Pharmacol 2007;47:13-8
7. Moodie JE, Brown CR, Bisley EJ, Weber HU, Bynum L. The safety and analgesic efficacy of intranasal ketorolac in patients with postoperative pain. Anesth Analg 2008;107:2025-31
8. Gonzalez-Martin G, Maggio L, Gonzalez-Sotomayor J, Zuniga S. Pharmacokinetics of ketorolac in children after abdominal surgery. Int J Clin Pharmacol Ther 1997;35:160-3
9. Zuppa AF, Mondick JT, Davis L, Cohen D. Population pharmacokinetics of ketorolac in neonates and young infants. Am J Ther 2009;16:143-6
10. Olkkola KT, Maunuksela EL. The pharmacokinetics of postoperative intravenous ketorolac tromethamine in children. Br J Clin Pharmacol 1991;31:182-4
11. Forrest JB, Heitlinger EL, Revell S. Ketorolac for postoperative pain management in children. Drug Saf 1997;16:309-29
12. Mandema JW, Stanski DR. Population pharmacodynamic model for ketorolac analgesia. Clin Pharmacol Ther 1996;60: 619-35
13. Watcha MF, Jones MB, Lagueruela RG, Schweiger C, White PF. Comparison of ketorolac and morphine as adjuVants during pediatric surgery. Anesthesiology 1992;76:368-72
14. Dsida RM, Wheeler M, Birmingham PK, Wang Z, Heffner CL, Cote CJ, Avram MJ. Age-stratified pharmacokinetics of ketorolac tromethamine in pediatric surgical patients. Anesth Analg 2002;94:266-70
15. Jallad NS, Garg DC, Martinez JJ, Mroszczak EJ, Weidler DJ. Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly. J Clin Pharmacol 1990;30:76-81
16. Jung D, Mroszczak E, Bynum L. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration. Eur J Clin Pharmacol 1988;35:423-5
17. Beal SL, Sheiner LB, Boeckmann A. Nonmem User's Guide. San Francisco: Division of Pharmacology, University of California, 1999
18. West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 1997;276:122-6
19. Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008;48:303-32
20. Anderson BJ, Allegaert K, Holford NH. Population clinical pharmacology of children: modelling covariate effects. Eur J Pediatr 2006;165:819-29
21. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1986;1:54-77
22. Post TM, Freijer JI, Ploeger BA, Danhof M. Extensions to the visual predictive check to facilitate model performance evaluation. J Pharmacokinet Pharmacodyn 2008;35:185-202
23. Tod M, Jullien V, Pons G. Facilitation of drug evaluation in children by population methods and modelling. Clin Pharmacokinet 2008;47:231-43
24. Brendel K, Dartois C, Comets E, Lemenuel-Diot A, Laveille C, Tranchand B, Girard P, Laffont CM, Mentre F. Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004. Clin Pharmacokinet 2007;46:221-34
25. Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J 2011;13:143-51
26. Dsida RM, Wheeler M, Birmingham PK, Henthorn TK, Avram MJ, Enders-Klein C, Maddalozzo J, Cote CJ. Premedication of pediatric tonsillectomy patients with oral transmucosal fentanyl citrate. Anesth Analg 1998;86:66-70
27. Gillis JC, Brogden RN. Ketorolac: a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 1997;53:139-88
28. Mroszczak EJ, Lee FW, Combs D, Sarnquist FH, Huang BL, Wu AT, Tokes LG, Maddox ML, Cho DK. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans. Drug Metab Dispos 1987; 15:618-26